Xspray Pharma’s Nomination Committee for the Annual General Meeting 2023
Regulatory press release 2022-10-25
Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) publishes the Nomination Committee’s composition for the Annual General Meeting in 2023.
The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on 19 May 2022, consists of:
- Thomas Eldered, appointed by Flerie Invest AB
- Johan Gyllenswärd, appointed by Ribbskottet AB
- Gillis Cullin, appointed by Östersjöstiftelsen
- Jan Särlvik, appointed by AP4
- Anders Ekblom, Chairman of the Board of Directors, Xspray Pharma AB
The Nomination Committee shall, before the Annual General Meeting 2023, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual Meeting, election of auditors, the determination of fees and matters pertaining thereto.
Shareholders who wish to submit proposals to the Nomination Committee prior to the Annual General Meeting on May 16, 2023, can do so via e-mail to firstname.lastname@example.org before March 28, 2023.
For further information about the Nomination Committee, please contact:
Anders Ekblom, Chairman of the Board of Directors, Xspray Pharma AB